Company: LRHC
Filing Date: 2025-02-25
Form Type: PRE 14C
Source: 0001213900-25-016765
Chunk: 6

Company: La Rosa Holdings Corp.
Filing Date: 2025-02-25
Form: PRE 14C
Chunk 6
---
250 in substantially the same form as the Initial Note (“Incremental Notes”;
and together with the Initial Note, the “Notes”). The purchase price paid by the Investor under the Securities Purchase Agreement
for the Initial Note and Incremental Warrants is $4,963,750. These proceeds have been or may be used by the Company to pay-off certain
indebtedness of the Company, pay certain outstanding fees and expenses (including expenses of the offering), acquisitions and general
corporate purposes.

Pursuant to the terms of the
Securities Purchase Agreement, the Company is required in the instant case, no later than sixty (60) days of the Closing Date (the “Stockholder
Meeting Deadline”): (x) to obtain the prior written consent of the requisite shareholders of the Company (the “Stockholder
Consent”) to obtain the Stockholder Approval (as defined below), which Stockholder Consent has been provided under the Majority
Stockholder Consent described above, and (y) to inform the other shareholders of the Company of the receipt of the Stockholder Consent
by preparing and filing with the Securities and Exchange Commission (the “Commission”) an information statement with respect
thereto as promptly as practicable after the Closing Date but prior to the Stockholder Meeting Deadline (or, if such filing is delayed
by a court or regulatory agency, in no event later than ninety (90) calendar days after the Closing Date). This Information Statement
is being provided to shareholders in satisfaction of the latter requirement.

The Majority Stockholder Consent
provides the affirmative stockholder approval required under the Securities Purchase Agreement (the “Stockholder Approval”)
of: (i) the issuance of the Initial Note, the Incremental Warrants and Incremental Notes, all Interest Shares and all of the Conversion
Shares and Incremental Conversion Shares in excess of 19.99% (without regard to any limitation on conversion or exercise thereof) of the
Company’s issued and outstanding Common Stock at a price less than the minimum price required by Nasdaq in compliance with the 20%
Rule; (ii) authorization to complete a reverse split of our Common Stock (the “Reverse Split”); and (iii) authorization to
increase the number authorized shares of our Common Stock (the “Required Authorized Shares Increase”) is sufficient to meet
the ensure that the number of shares that the Company can reserved for issuance by the Company upon conversion of the Initial Note and
any Incremental Notes issuable upon exercise of any Incremental Warrants